2023 has proven to be a remarkable year for Parkinson's research. The recent discovery of a biomarker for Parkinson’s allows the disease to be detected in individuals, even before symptoms appear. For the new year, our researchers are aiming to: ➡️ Integrate the biomarker into trials to pinpoint how early the disease begins. ➡️ Accelerate testing of potentially preventative therapeutics for Parkinson’s disease. ➡️ Broaden the biomarker’s use in research and care by developing easy methods to det

On the heels of a transformative year for Parkinson’s disease research, Shalini Padmanabhan, our vice president of discovery and translational research, highlights the progress we have made and all that lies ahead. From the discovery of a biomarker to the identification of a gene variant associated with higher Parkinson’s risk – recent discoveries are rapidly accelerating our search for improved therapies and a cure for the disease. | The Michael J. Fox Foundation for Parkinson's Research